Evogene Set to Showcase Key Pharma Innovations at BIO-Europe Spring 2026 At BIO-Europe Spring 2026, Evogene Ltd. aims to highlight its groundbreaking advancements in pharmaceutical discovery driven by AI. This event is pivotal in displaying their innovative technologies.

Evogene Set to Showcase Key Pharma Innovations at BIO-Europe Spring 2026 #Portugal #Lisbon #Evogene #ChemPass_AI #Pharma_Discovery

Evogene Reports Significant Financial Adjustments for Fourth Quarter and Full Year 2025 Evogene Ltd. announces financial results for Q4 and full year 2025, highlighting a strategic focus on its ChemPass AI™ platform for drug discovery.

Evogene Reports Significant Financial Adjustments for Fourth Quarter and Full Year 2025 #Israel #financial_results #Rehovot #Evogene #ChemPass_AI

Evogene's Transformative Strategy to Create Long-Term Value for Shareholders Discover Evogene's significant advancements and strategic transformation, focusing on long-term value creation in pharmaceuticals and agriculture.

Evogene's Transformative Strategy to Create Long-Term Value for Shareholders #Israel #Rehovot #Evogene #ChemPass_AI #Ofer_Haviv

Evogene Secures $3.4 Million from Warrant Inducement Deal to Boost Growth Evogene Ltd. has announced a warrant inducement agreement generating $3.4 million in gross proceeds to support its innovative efforts in chemistry.

Evogene Secures $3.4 Million from Warrant Inducement Deal to Boost Growth #Israel #Rehovot #Warrant_Inducement #Evogene #ChemPass_AI

Evogene and Google Cloud Collaborate to Enhance AI in ChemPass AI™ for Drug Development Evogene extends its partnership with Google Cloud, integrating AI agents into ChemPass AI™ to enhance small-molecule discovery, promising quicker pharmaceutical development.

Evogene and Google Cloud Collaborate to Enhance AI in ChemPass AI™ for Drug Development #Israel #Google_Cloud #Rehovot #Evogene #ChemPass_AI

Evogene Strengthens Scientific Leadership by Appointing Two Professors to Advisory Board Evogene Ltd. enhances its scientific team by announcing the appointment of two renowned professors. This move aims to support its innovative ChemPass AI™.

Evogene Strengthens Scientific Leadership by Appointing Two Professors to Advisory Board #Israel #Rehovot #Evogene #ChemPass_AI #John_Irwin

Evogene Names Dr. Olga Nissan as New VP of Business Development to Drive Growth Dr. Olga Nissan has been appointed VP of Business Development at Evogene, bringing extensive expertise in biotech and pharma to accelerate innovation.

Evogene Names Dr. Olga Nissan as New VP of Business Development to Drive Growth #Israel #Rehovot #Evogene #ChemPass_AI #Dr._Nissan

Evogene to Showcase Innovative ChemPass AI Strategy at H.C. Wainwright Global Conference Evogene's CEO Ofer Haviv will present the company's ChemPass AI strategy at the H.C. Wainwright 27th Annual Global Investment Conference in New York, focusing on advancements in small molecule discovery.

Evogene to Showcase Innovative ChemPass AI Strategy at H.C. Wainwright Global Conference #United_States #New_York #Evogene #ChemPass_AI #Ofer_Haviv

Evogene's Q2 2025 Financial Results Highlight Strategic Shift and Future Opportunities Evogene has shared its second quarter 2025 financial results, revealing significant strategic changes and future prospects in pharmaceuticals and agriculture.

Evogene's Q2 2025 Financial Results Highlight Strategic Shift and Future Opportunities #Israel #Rehovot #Evogene #Lavie_Bio #ChemPass_AI